ARKK Holdings of MCRB
Seres Therapeutics
Seres Therapeutics, Inc. operates as a biotechnology company focused on developing microbiome therapeutics aimed at treating diseases by restoring the human microbiome's natural state. The company generates revenue through collaborations, research funding, and potential future sales of its therapeutic products once they receive regulatory approval and reach the market.
Trades of MCRB in ARKK
The ten most recent trades of Seres Therapeutics in the ARKK ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Sep 07, 2021 | Sell | $1,755 | 50.00% | 0.00% |
| Sep 03, 2021 | Sell | $80,562 | 4,560.00% | 0.00% |
| Sep 02, 2021 | Sell | $333,000 | 407.96% | 0.00% |
| Sep 01, 2021 | Sell | $336,422 | 83.43% | 0.00% |
| Aug 31, 2021 | Sell | $3,633,601 | 504.21% | 0.02% |
| Aug 30, 2021 | Sell | $5,303,122 | 122.34% | 0.02% |
| Aug 27, 2021 | Sell | $3,576,500 | 37.28% | 0.02% |
| Aug 24, 2021 | Sell | $285,476 | 2.13% | 0.00% |
| Aug 23, 2021 | Sell | $1,162,404 | 8.49% | 0.01% |
| Aug 19, 2021 | Sell | $67,545 | 0.46% | 0.00% |